Stock Events

Stock Events

Anteris Technologies Global 

$9.69
27
-$0.19-1.92% 20:00 Today
+$0.00+0%20:43After hours

Statistics

Day High
10.25
Day Low
9.5
52W High
10.56
52W Low
2.85
Volume
3,268,853
Avg. Volume
1,037,522
Mkt Cap
399.21M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-1.07
-0.78
-0.49
-0.21
Expected EPS
-0.2073
Actual EPS
N/A

Financials

-2,822.46%Profit Margin
Unprofitable
2023
2024
5.41MRevenue
-152.58MNet Income

Analyst Ratings

16.33Average Price Target
The highest estimate is 18.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AVR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Edwards Lifesciences
EW
Mkt Cap50.3B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, directly competing with Anteris's focus on cardiovascular devices.
Medtronic
MDT
Mkt Cap101.56B
Medtronic offers a broad range of medical devices including those for cardiovascular therapy, competing in similar markets as Anteris Technologies.
Boston Scientific
BSX
Mkt Cap67.32B
Boston Scientific produces medical devices used in interventional medical specialties, including cardiovascular, competing with Anteris's product offerings.
Abbott Laboratories
ABT
Mkt Cap153.99B
Abbott Laboratories has a wide range of medical devices, including for cardiovascular health, making it a competitor in the same space as Anteris.
Stryker
SYK
Mkt Cap118B
Stryker Corporation is involved in medical technologies, including surgical equipment and neurovascular products, indirectly competing with Anteris's focus areas.
Zimmer Biomet
ZBH
Mkt Cap17.02B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but its innovations in medical devices place it as a competitor in the broader medical device market.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical, known for its robotic surgical systems, competes in the innovative medical device space, indirectly affecting companies like Anteris.
Baxter International
BAX
Mkt Cap10.27B
Baxter International develops, manufactures, and markets healthcare products, including hospital and renal care products, competing in the healthcare solutions sector.
Johnson & Johnson
JNJ
Mkt Cap549.78B
Johnson & Johnson's medical device segment offers a broad range of products that compete across various sectors, including cardiovascular.
Integra Lifesciences
IART
Mkt Cap1.37B
Integra LifeSciences, a provider of regenerative technologies, surgical instrumentation, and neurosurgical products, competes in the medical technology and device market.

About

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
Show more...
CEO
Mr. Wayne Geoffrey Paterson
Employees
136
Country
United States
ISIN
US03675P1021

Listings

XNAS
US
AVR
AU
AU
AVR.AU
BOATS
BOATS
AVR.BOATS

0 Comments

Share your thoughts

FAQ

What is Anteris Technologies Global stock price today?▼
The current price of AVR is $9.69 USD — it has decreased by -1.92% in the past 24 hours. Watch Anteris Technologies Global stock price performance more closely on the chart.
What is Anteris Technologies Global stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Anteris Technologies Global stocks are traded under the ticker AVR.
Is Anteris Technologies Global stock price growing?▼
AVR stock has fallen by -0.92% compared to the previous week, the month change is a +6.72% rise, over the last year Anteris Technologies Global has showed a +142.25% increase.
What is Anteris Technologies Global market cap?▼
Today Anteris Technologies Global has the market capitalization of 399.21M
When is the next Anteris Technologies Global earnings date?▼
Anteris Technologies Global is going to release the next earnings report on August 17, 2026.
What were Anteris Technologies Global earnings last quarter?▼
AVR earnings for the last quarter are -0.28 USD per share, whereas the estimation was -0.27 USD resulting in a -3.38% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Anteris Technologies Global revenue for the last year?▼
Anteris Technologies Global revenue for the last year amounts to 5.41M USD.
What is Anteris Technologies Global net income for the last year?▼
AVR net income for the last year is -152.58M USD.
How many employees does Anteris Technologies Global have?▼
As of June 26, 2026, the company has 136 employees.
In which sector is Anteris Technologies Global located?▼
Anteris Technologies Global operates in the Health & Wellness sector.
When did Anteris Technologies Global complete a stock split?▼
The last stock split for Anteris Technologies Global was on February 21, 2006 with a ratio of 1:50.
Where is Anteris Technologies Global headquartered?▼
Anteris Technologies Global is headquartered in Toowong, United States.